Skip to Content

GP practice wins Innovation Challenge award for use of Alere Afinion CRP

The NHS Innovation Challenge Prizes took place on 28 January 2016. The challenge seeks to encourage, recognize and reward front line innovation and support the adoption of these innovations across the NHS.

GP practice wins Innovation Challenge award for use of Alere Afinion CRP

Over the last four years the NHS Innovation Challenge Prizes have helped to identify and spread proven innovations, promoting a culture of invention and driving adoption of the best ideas.

This year, Alere was recognized when Liz Cross, Nurse Practitioner, and Dr. David Zimmel, GP, both from Attenborough Surgery in Watford, were one of 4 winners of the Acorn Challenge Prize, an open innovation fund, for which they were awarded £10,000 for their work using Alere™ Afinion CRP in their GP practice to help reduce prescribing rates and re-attendances.

Ms. Cross told GP Magazine, “I was kind of expecting [antibiotic prescribing to drop], but the most interesting part for me was if I don’t prescribe antibiotics – last winter, if I didn’t prescribe antibiotics when patients came in with their chesty coughs, a quarter would come back and they would present to a GP, out-of-hours, or A&E."

"And now, if I don’t prescribe and have done the CRP test, 4% come back. So my re-attendance rates are really reduced and my cost savings are through that. I save about £100 a month, after paying for the tests, on prescribing and reduced follow up appointments. It doesn't sound much but it means the project is sustainable and patients get better quality care.”1

All entries were judged by an Expert Panel, consisting of some of the England’s most senior healthcare leaders and innovators.  Aligned to the NHS Outcomes Framework – 5 domains resources, the panel looked for innovations that can demonstrate:

  • Improved outcomes for patients and better value for money
  • New models of delivering care that flexible and responsive to the needs of local communities
  • Innovative ways of harnessing the coming innovations in modern medicine
  • Personalised services that reflect the needs and expectations of patients and their families

The prize had over 400 expressions of interest, 215 final applicants and 4 judging panels.

To learn more about the NHS Innovation Challenge Prizes, visit their website.

Explore TestTargetTreat.com to learn more about rapid diagnostic solutions from Alere and their role in antimicrobial stewardship.

The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Abbott or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Abbott or TestTargetTreat.com. Neither Abbott nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.

Explore Related Content and Videos

C. difficile Patient Pathway

Which pathway would you choose for you patient?

Pick a pathway

Vietnamese study shows C-reactive protein testing significantly reduces inappropriate use of antibiotics.

Vietnamese study shows C-reactive protein testing significantly reduces inappropriate use of antibiotics.

Read more

ITV News Video

ITV News reports on the O'Neill Review and features the point-of-care Alere Afinion™ CRP test being used in primary care.